NATTOPHARMA APPLY FOR DELISTING FROM NASDAQ FIRST NORTH
The Board of Directors of NattoPharma ASA has resolved to apply for delisting of the company's shares from Nasdaq First North.Information about the last trading date on Nasdaq First North will be made public well in advance through a press release from the company. The reason for this decision of desired delisting is that the company is primarily listed on Oslo Axess and due to low trading volumes on both Oslo Axess and Nasdaq First North, the board wishes to consolidate all trading in one marketplace with the aim of increasing the activity in the stock and thereby give shareholders a